Clinical Trial Update: GTP Regimen in the Treatment of Refractory/Recurrent HLH [Phase 3]

View source ↗

Summary

Phase 3 trial update for the GTP regimen in difficult-to-treat hemophagocytic lymphohistiocytosis (HLH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• GTP regimen

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Refractory, Recurrence | Phase 3 | Status: UNKNOWN